Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Fetal outcomes after rituximab exposure in women with autoimmune vasculitis.

Literature DB >> 23864238

Fetal outcomes after rituximab exposure in women with autoimmune vasculitis.

William F Pendergraft¹, Martina M McGrath, Andrew P Murphy, Patrick Murphy, Karen A Laliberte, Michael F Greene, John L Niles.

Abstract

Entities: Chemical Disease Gene Species

Keywords: Autoimmunity; B cells; Systemic vasculitis

Mesh：

Substances：

Year: 2013 PMID： 23864238 PMCID： PMC4408892 DOI： 10.1136/annrheumdis-2013-203833

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

× No keyword cloud information.

6 in total

1. Pregnancy in women diagnosed with antineutrophil cytoplasmic antibody-associated vasculitis: outcome for the mother and the child.

Authors: J Tuin; J S F Sanders; A A E de Joode; C A Stegeman
Journal: Arthritis Care Res (Hoboken) Date: 2012-04 Impact factor: 4.794

2. Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

Authors: John H Stone; Peter A Merkel; Robert Spiera; Philip Seo; Carol A Langford; Gary S Hoffman; Cees G M Kallenberg; E William St Clair; Anthony Turkiewicz; Nadia K Tchao; Lisa Webber; Linna Ding; Lourdes P Sejismundo; Kathleen Mieras; David Weitzenkamp; David Ikle; Vicki Seyfert-Margolis; Mark Mueller; Paul Brunetta; Nancy B Allen; Fernando C Fervenza; Duvuru Geetha; Karina A Keogh; Eugene Y Kissin; Paul A Monach; Tobias Peikert; Coen Stegeman; Steven R Ytterberg; Ulrich Specks
Journal: N Engl J Med Date: 2010-07-15 Impact factor: 91.245

3. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.

Authors: Rachel B Jones; Jan Willem Cohen Tervaert; Thomas Hauser; Raashid Luqmani; Matthew D Morgan; Chen Au Peh; Caroline O Savage; Mårten Segelmark; Vladimir Tesar; Pieter van Paassen; Dorothy Walsh; Michael Walsh; Kerstin Westman; David R W Jayne
Journal: N Engl J Med Date: 2010-07-15 Impact factor: 91.245

4. Pregnancy outcomes after maternal exposure to rituximab.

Authors: Eliza F Chakravarty; Elaine R Murray; Ariella Kelman; Pamela Farmer
Journal: Blood Date: 2010-11-23 Impact factor: 22.113

Review 5. Beckwith-Wiedemann syndrome.

Authors: Rosanna Weksberg; Cheryl Shuman; J Bruce Beckwith
Journal: Eur J Hum Genet Date: 2010-01 Impact factor: 4.246

Review 6. IgG placental transfer in healthy and pathological pregnancies.

Authors: Patricia Palmeira; Camila Quinello; Ana Lúcia Silveira-Lessa; Cláudia Augusta Zago; Magda Carneiro-Sampaio
Journal: Clin Dev Immunol Date: 2011-10-01

6 in total

7 in total

Review 1. Use of DMARDs and biologics during pregnancy and lactation in rheumatoid arthritis: what the rheumatologist needs to know.

Authors: Megan L Krause; Shreyasee Amin; Ashima Makol
Journal: Ther Adv Musculoskelet Dis Date: 2014-10 Impact factor: 5.346

Review 2. Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era.

Authors: Loredana Colla; Davide Diena; Maura Rossetti; Ana Maria Manzione; Luca Marozio; Chiara Benedetto; Luigi Biancone
Journal: J Nephrol Date: 2018-02-23 Impact factor: 3.902

Review 3. Place in therapy of rituximab in the treatment of granulomatosis with polyangiitis and microscopic polyangiitis.

Authors: Shivani Shah; Duvuru Geetha
Journal: Immunotargets Ther Date: 2015-08-07